TARGET-SCD

Professor Olivier Hermine leads a research team and a clinical department at Institut Imagine and Institut de la Leucémie, where he combines fundamental research and patient care to advance innovative approaches for hematological diseases.

This distinction highlights an ambitious five-year project: TARGET-SCD, which combines mechanistic investigations and the development of personalized innovative therapeutic strategies for sickle cell disease. TARGET-SCD is led by Université Paris Cité in partnership with Institut Imagine

“Our goal is to improve our knowledge in basic science of erythropoiesis and inflammation, and most of all move beyond treating the consequences of sickle cell disease and instead target its root causes. By combining cutting-edge science with translational research, we aim to bring the right treatment to the right patient at the right time.”
Prof. Hermine

This project has the potential to transform our understanding of sickle cell disease and accelerate the development of personalized therapies.